L. Roy Papp & Associates LLP Sells 1,453 Shares of The Clorox Company $CLX

L. Roy Papp & Associates LLP trimmed its position in shares of The Clorox Company (NYSE:CLXFree Report) by 9.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 13,981 shares of the company’s stock after selling 1,453 shares during the quarter. L. Roy Papp & Associates LLP’s holdings in Clorox were worth $1,679,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in CLX. Park Avenue Securities LLC acquired a new stake in Clorox during the first quarter valued at approximately $258,000. Farther Finance Advisors LLC boosted its holdings in Clorox by 25.4% during the first quarter. Farther Finance Advisors LLC now owns 5,872 shares of the company’s stock valued at $869,000 after purchasing an additional 1,190 shares in the last quarter. Pallas Capital Advisors LLC acquired a new stake in Clorox during the first quarter valued at approximately $647,000. Wealthcare Advisory Partners LLC boosted its holdings in Clorox by 47.8% during the first quarter. Wealthcare Advisory Partners LLC now owns 2,350 shares of the company’s stock valued at $346,000 after purchasing an additional 760 shares in the last quarter. Finally, Simplicity Wealth LLC acquired a new stake in Clorox during the first quarter valued at approximately $1,048,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Jefferies Financial Group decreased their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. TD Cowen reduced their target price on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. Bank of America reduced their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. boosted their target price on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $132.54.

Get Our Latest Analysis on Clorox

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.3%

NYSE:CLX opened at $119.98 on Friday. The stock’s fifty day moving average price is $122.27 and its two-hundred day moving average price is $128.94. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $14.67 billion, a price-to-earnings ratio of 18.40, a P/E/G ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the prior year, the business earned $1.82 EPS. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox’s dividend payout ratio is currently 76.07%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.